Overview

Efficacy and Safety of SOM3355 in Huntington's Disease Chorea

Status:
Completed
Trial end date:
2019-08-22
Target enrollment:
Participant gender:
Summary
Phase IIa study to evaluate the efficacy and safety of SOM3355 in chorea movements associated with Huntington's disease
Phase:
Phase 2
Details
Lead Sponsor:
SOM Biotech SL